Van Dyck M - Search Results

1

Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients.

Claeys T, Van Dyck M, Van Damme-Lombaerts R. Claeys T, et al. Among authors: van damme lombaerts r, van dyck m. Pediatr Nephrol. 2010 Feb;25(2):335-42. doi: 10.1007/s00467-009-1331-6. Epub 2009 Nov 3. Pediatr Nephrol. 2010. PMID: 19885684

2

Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.

Knops N, Herman J, van Dyck M, Ramazani Y, Debbaut E, van Damme-Lombaerts R, Levtchenko E, van den Heuvel LP, Fieuws S, Kuypers D. Knops N, et al. Among authors: van damme lombaerts r, van dyck m, van den heuvel lp. Br J Clin Pharmacol. 2017 Apr;83(4):863-874. doi: 10.1111/bcp.13174. Epub 2016 Dec 13. Br J Clin Pharmacol. 2017. PMID: 27966227 Free PMC article.

3

Reversible arterial spasm in an adolescent with primary oxalosis.

van Damme-Lombaerts R, Proesmans W, Alexandre G, van Dyck M, Serrus M, Wilms G. van Damme-Lombaerts R, et al. Among authors: van dyck m. Clin Nephrol. 1988 Oct;30(4):235-8. Clin Nephrol. 1988. PMID: 3063419 Review.

4

Impact of growth hormone treatment on a Belgian population of short children with renal allografts.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Schurmans T, Herman J, Hooghe L, Van Damme B. Janssen F, et al. Among authors: van damme lombaerts r, van dyck m, van damme b. Pediatr Transplant. 1997 Nov;1(2):190-6. Pediatr Transplant. 1997. PMID: 10084780

5

Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Proesmans W, Goos G, Kinnaert P. Janssen F, et al. Among authors: van damme lombaerts r, van dyck m. Transplant Proc. 1993 Feb;25(1 Pt 2):1049-50. Transplant Proc. 1993. PMID: 8442037 No abstract available.

6

Conservative treatment for chronic renal failure from birth: a 3-year follow-up study.

Van Dyck M, Bilem N, Proesmans W. Van Dyck M, et al. Pediatr Nephrol. 1999 Nov;13(9):865-9. doi: 10.1007/s004670050717. Pediatr Nephrol. 1999. PMID: 10603138 Clinical Trial.

7

Growth hormone therapy in chronic renal failure induces catch-up of head circumference.

Van Dyck M, Proesmans W. Van Dyck M, et al. Pediatr Nephrol. 2001 Aug;16(8):631-6. doi: 10.1007/s004670100617. Pediatr Nephrol. 2001. PMID: 11519892

8

3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.

Breysem L, De Rechter S, De Keyzer F, Smet MH, Bammens B, Van Dyck M, Hofmans M, Oyen R, Levtchenko E, Mekahli D. Breysem L, et al. Among authors: van dyck m. Pediatr Nephrol. 2018 May;33(5):827-835. doi: 10.1007/s00467-017-3862-6. Epub 2018 Jan 6. Pediatr Nephrol. 2018. PMID: 29306987

9

Enalapril in children with Alport syndrome.

Proesmans W, Van Dyck M. Proesmans W, et al. Among authors: van dyck m. Pediatr Nephrol. 2004 Mar;19(3):271-5. doi: 10.1007/s00467-003-1366-z. Epub 2004 Jan 24. Pediatr Nephrol. 2004. PMID: 14745635 Clinical Trial.

10

Vitamin D metabolites in childhood nephrotic syndrome.

Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R. Grymonprez A, et al. Among authors: van dyck m. Pediatr Nephrol. 1995 Jun;9(3):278-81. doi: 10.1007/BF02254183. Pediatr Nephrol. 1995. PMID: 7632510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page